Latest news with #Revenue
The Hindu
3 hours ago
- Politics
- The Hindu
Anagani alleges Jagan, Roja ‘stumbling blocks' in State's development
Minister for Revenue, Stamps and Registration Anagani Satya Prasad on Tuesday alleged that former Chief Minister Y.S. Jagan Mohan Reddy and former minister R.K. Roja were acting like 'stumbling blocks' in the State's development. Speaking to the media here on Tuesday (July 22), he said that it was 'below dignity' for him to speak on some politicians who were bent on stalling development in the State. 'Our Chief Minister N. Chandrababu Naidu made 56 field level trips across the State during the last 13 months, but our former Chief Minister does not even have the intention of attending the Assembly sessions. If Jagan is really interested in the people's welfare, why does not he attend the Assembly?', he asked. The Minister joined MLAs Arani Srinivasulu (Tirupati) and Bojjala Venkata Sudhir Reddy (Srikalahasti), MCT Commissioner N. Mourya and Andhra Pradesh Greening and Beautification Corporation Chairperson M. Sugunamma to celebrate the city's impressive 'Swachh Survekshan' rankings in an event organised by the MCT.
Yahoo
7 hours ago
- Business
- Yahoo
IQVIA Reports Second-Quarter 2025 Results
Revenue of $4,017 million, up 5.3 percent year-over-year GAAP Net Income of $266 million, Adjusted EBITDA of $910 million GAAP Diluted Earnings per Share of $1.54, Adjusted Diluted Earnings per Share of $2.81 R&D Solutions quarterly bookings of $2.5 billion, representing a book-to-bill ratio of 1.12x R&D Solutions contracted backlog of $32.1 billion, up 5.1 percent year-over-year TAS Revenue of $1,628 million, up 8.9 percent year-over-year Repurchased $607 million of common stock in the quarter, over $1 billion year-to-date RESEARCH TRIANGLE PARK, N.C., July 22, 2025--(BUSINESS WIRE)--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended June 30, 2025. Second-Quarter 2025 Operating Results Revenue for the second quarter of $4,017 million increased 5.3 percent on a reported basis and 3.6 percent at constant currency, compared to the second quarter of 2024. Technology & Analytics Solutions (TAS) revenue of $1,628 million increased 8.9 percent on a reported basis and 6.8 percent at constant currency. Research & Development Solutions (R&DS) revenue of $2,201 million increased 2.5 percent on a reported basis and 1.3 percent at constant currency. Excluding reimbursed expenses, R&DS revenue grew 1.8 percent on a reported basis. Contract Sales & Medical Solutions (CSMS) revenue of $188 million increased 9.3 percent on a reported basis and 6.4 percent at constant currency. As of June 30, 2025, R&DS contracted backlog was $32.1 billion, growing 5.1 percent year-over-year and 3.2 percent at constant currency. The company expects approximately $8.1 billion of this backlog to convert to revenue in the next twelve months, representing growth of 4.8 percent year-over-year. Second quarter net new bookings were $2.5 billion, representing a book-to-bill ratio of 1.12x, and resulting in a trailing-twelve-month book-to-bill ratio of 1.10x. Second-quarter GAAP Net Income was $266 million and GAAP Diluted Earnings per Share was $1.54. Adjusted EBITDA was $910 million, up 2.6 percent year-over-year. Adjusted Net Income was $486 million and Adjusted Diluted Earnings per Share was $2.81. "IQVIA delivered strong financial results, with revenue above target and profit towards the high-end of expectations," said Ari Bousbib, chairman and CEO of IQVIA. "Our TAS segment performed well with high single digits year-over-year revenue growth. In the clinical development business, forward-looking demand indicators improved, with net bookings up 15 percent quarter-over-quarter, and RFP flow growing high single digits sequentially and low teens year-over-year. These results underscore the resilience of our global diversified portfolio and the team's ability to execute consistently against our strategic and financial objectives." First-Half 2025 Operating Results Revenue for the first six months of 2025 was $7,846 million, up 3.9 percent on a reported basis and 3.5 percent at constant currency, compared to the first six months of 2024. TAS revenue was $3,174 million, representing growth of 7.7 percent on a reported basis and 7.2 percent at constant currency. R&DS revenue was $4,303 million, up 1.4 percent on a reported basis and 1.2 percent at constant currency. CSMS revenue was $369 million, up 2.2 percent on a reported basis and 1.9 percent at constant currency. GAAP Net Income was $515 million and GAAP Diluted Earnings per Share was $2.94. Adjusted Net Income was $965 million and Adjusted Diluted Earnings per Share was $5.50. Adjusted EBITDA was $1,793 million. Financial Position As of June 30, 2025, cash and cash equivalents were $2,039 million and debt was $15,490 million, resulting in net debt of $13,451 million. IQVIA's Net Leverage Ratio was 3.61x trailing twelve-month Adjusted EBITDA. For the second quarter, Operating Cash Flow was $443 million and Free Cash Flow was $292 million. Share Repurchase During the second quarter of 2025, the company repurchased $607 million of its common stock, resulting in first-half share repurchases of $1,032 million. IQVIA had $1,981 million of share repurchase authorization remaining as of June 30, 2025. Full-Year 2025 Guidance The company is updating its full-year 2025 guidance as follows: revenue between $16,100 million and $16,300 million, Adjusted EBITDA between $3,750 million and $3,825 million, and Adjusted Diluted Earnings per Share between $11.75 and $12.05. This revenue guidance assumes approximately $100 million of COVID-related revenue step-down, entirely in R&DS, approximately 100 basis points of tailwind from foreign exchange, and approximately 150 basis points of contribution from acquisitions. All financial guidance assumes foreign currency exchange rates as of July 21, 2025 remain in effect for the forecast period. Webcast & Conference Call Details IQVIA will host a conference call at 9:00 a.m. Eastern Time today to discuss its second-quarter 2025 results and its third-quarter and full-year 2025 guidance. To listen to the event and view the presentation slides via webcast, join from the IQVIA Investor Relations website at To participate in the conference call, interested parties must register in advance by clicking on this link. Following registration, participants will receive a confirmation email containing details on how to join the conference call, including the dial-in and a unique passcode and registrant ID. At the time of the live event, registered participants connect to the call using the information provided in the confirmation email and will be placed directly into the call. About IQVIA IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA's portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using artificial intelligence ("AI") responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 90,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit Cautionary Statements Regarding Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, without limitation, our full-year 2025 guidance. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "assume," "anticipate," "intend," "plan," "forecast," "believe," "seek," "see," "will," "would," "target," similar expressions, and variations or negatives of these words that are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from our expectations due to a number of factors, including, but not limited to, the following: business disruptions caused by natural disasters, pandemics such as the COVID-19 (coronavirus) outbreak, including any variants, and the public health policy responses to the outbreak, and international conflicts or other disruptions outside of our control; most of our contracts may be terminated on short notice, and we may lose or experience delays with large client contracts or be unable to enter into new contracts; the market for our services may not grow as we expect; we may be unable to successfully develop and market new services or enter new markets; imposition of restrictions on our use of data by data suppliers or their refusal to license data to us; any failure by us to comply with contractual, regulatory or ethical requirements under our contracts, including current or future changes to data protection and privacy laws; breaches or misuse of our or our outsourcing partners' security or communications systems; failure to meet our productivity or business transformation objectives; failure to successfully invest in growth opportunities; our ability to protect our intellectual property rights and our susceptibility to claims by others that we are infringing on their intellectual property rights; the expiration or inability to acquire third party licenses for technology or intellectual property; any failure by us to accurately and timely price and formulate cost estimates for contracts, or to document change orders; hardware and software failures, delays in the operation of our computer and communications systems or the failure to implement system enhancements; the rate at which our backlog converts to revenue; our ability to acquire, develop and implement technology necessary for our business; consolidation in the industries in which our clients operate; risks related to client or therapeutic concentration; government regulators or our customers may limit the number or scope of indications for medicines and treatments or withdraw products from the market, and government regulators may impose new regulatory requirements or may adopt new regulations affecting the biopharmaceutical industry; the risks associated with operating on a global basis, including currency or exchange rate fluctuations and legal compliance, including anti-corruption laws; risks related to the enactment of legislation or the imposition of regulations or other restrictions or actions by governments that create business uncertainty and have the potential to limit trade; risks related to changes in accounting standards; general economic conditions in the markets in which we operate, including financial market conditions, inflation, and risks related to sales to government entities; the impact of changes in tax laws and regulations; and our ability to successfully integrate, and achieve expected benefits from, our acquired businesses. For a further discussion of the risks relating to our business, see the "Risk Factors" in our annual report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Securities and Exchange Commission (the "SEC"), as such factors may be amended or updated from time to time in our subsequent periodic and other filings with the SEC, which are accessible on the SEC's website at These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in our filings with the SEC. We assume no obligation to update any such forward-looking statement after the date of this release, whether as a result of new information, future developments or otherwise. Note on Non-GAAP Financial Measures This release includes information based on financial measures that are not recognized under generally accepted accounting principles in the United States ("GAAP"), such as Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted Earnings per Share, Gross Leverage Ratio, Net Leverage Ratio and Free Cash Flow. Non-GAAP financial measures are presented only as a supplement to the company's financial statements based on GAAP. Non-GAAP financial information is provided to enhance understanding of the company's financial performance, but none of these non-GAAP financial measures are recognized terms under GAAP, and non-GAAP measures should not be considered in isolation from, or as a substitute analysis for, the company's results of operations as determined in accordance with GAAP. The company uses non-GAAP measures in its operational and financial decision making, and believes that it is useful to exclude certain items in order to focus on what it regards to be a more meaningful indicator of the underlying operating performance of the business. For example, the company excludes all the amortization of intangible assets associated with acquired customer relationships and backlog, databases, non-compete agreements, trademarks and trade names from non-GAAP expense and income measures as such amounts can be significantly impacted by the timing and size of acquisitions. Although we exclude amortization of acquired intangible assets from our non-GAAP expenses, we believe that it is important for investors to understand that revenue generated from such intangibles is included within revenue in determining net income. As a result, internal management reports feature non-GAAP measures which are also used to prepare strategic plans and annual budgets and review management compensation. The company also believes that investors may find non-GAAP financial measures useful for the same reasons, although investors are cautioned that non-GAAP financial measures are not a substitute for GAAP disclosures. The non-GAAP financial measures are not presented in accordance with GAAP. Please refer to the schedules attached to this release for reconciliations of non-GAAP financial measures contained herein to the most directly comparable GAAP measures. Our full-year 2025 guidance measures (other than revenue) are provided on a non-GAAP basis without a reconciliation to the most directly comparable GAAP measure because the company is unable to predict with a reasonable degree of certainty certain items contained in the GAAP measures without unreasonable efforts. For the same reasons, the company is unable to address the probable significance of the unavailable information. Such items include, but are not limited to, acquisition related expenses, restructuring and related expenses, stock-based compensation and other items not reflective of the company's ongoing operations. Non-GAAP measures are frequently used by securities analysts, investors and other interested parties in their evaluation of companies comparable to the company, many of which present non-GAAP measures when reporting their results. Non-GAAP measures have limitations as an analytical tool. They are not presentations made in accordance with GAAP, are not measures of financial condition or liquidity and should not be considered as an alternative to profit or loss for the period determined in accordance with GAAP or operating cash flows determined in accordance with GAAP. Non-GAAP measures are not necessarily comparable to similarly titled measures used by other companies. As a result, you should not consider such performance measures in isolation from, or as a substitute analysis for, the company's results of operations as determined in accordance with GAAP. IQVIAFIN # # # Table 1IQVIA HOLDINGS INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF INCOME(preliminary and unaudited) Three Months Ended June 30, Six Months Ended June 30, (in millions, except per share data) 2025 2024 2025 2024 Revenues $ 4,017 $ 3,814 $ 7,846 $ 7,551 Cost of revenues, exclusive of depreciation and amortization 2,694 2,488 5,225 4,932 Selling, general and administrative expenses 509 509 1,017 1,017 Depreciation and amortization 276 269 541 533 Restructuring costs 32 28 61 43 Income from operations 506 520 1,002 1,026 Interest income (10 ) (12 ) (21 ) (23 ) Interest expense 182 163 347 329 Loss on extinguishment of debt — — 4 — Other expense (income), net 11 (67 ) 26 (56 ) Income before income taxes and equity in (losses) earnings of unconsolidated affiliates 323 436 646 776 Income tax expense 56 75 117 124 Income before equity in (losses) earnings of unconsolidated affiliates 267 361 529 652 Equity in (losses) earnings of unconsolidated affiliates (1 ) 2 (14 ) (1 ) Net income $ 266 $ 363 $ 515 $ 651 Earnings per share attributable to common stockholders: Basic $ 1.55 $ 1.99 $ 2.96 $ 3.58 Diluted $ 1.54 $ 1.97 $ 2.94 $ 3.53 Weighted average common shares outstanding: Basic 171.8 182.2 173.7 182.0 Diluted 173.2 184.3 175.3 184.3 Table 2IQVIA HOLDINGS INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS(preliminary and unaudited) (in millions, except per share data) June 30, 2025 December 31, 2024 ASSETS Current assets: Cash and cash equivalents $ 2,039 $ 1,702 Trade accounts receivable and unbilled services, net 3,344 3,204 Prepaid expenses 200 154 Income taxes receivable 62 36 Investments in debt, equity and other securities 149 141 Other current assets and receivables 551 592 Total current assets 6,345 5,829 Property and equipment, net 536 535 Operating lease right-of-use assets 280 238 Investments in debt, equity and other securities 134 108 Investments in unconsolidated affiliates 272 266 Goodwill 15,611 14,710 Other identifiable intangibles, net 4,596 4,499 Deferred income taxes 345 194 Deposits and other assets, net 513 520 Total assets $ 28,632 $ 26,899 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $ 3,399 $ 3,684 Unearned income 2,123 1,779 Income taxes payable 124 156 Current portion of long-term debt 1,313 1,145 Other current liabilities 613 193 Total current liabilities 7,572 6,957 Long-term debt, less current portion 14,177 12,838 Deferred income taxes 216 196 Operating lease liabilities 210 173 Other liabilities 671 668 Total liabilities 22,846 20,832 Commitments and contingencies Stockholders' equity: Common stock and additional paid-in capital, 400.0 shares authorized as of June 30, 2025 and December 31, 2024, $0.01 par value, 258.5 shares issued and 170.0 shares outstanding as of June 30, 2025; 258.2 shares issued and 176.1 shares outstanding as of December 31, 2024 11,225 11,143 Retained earnings 6,580 6,065 Treasury stock, at cost, 88.5 and 82.1 shares as of June 30, 2025 and December 31, 2024, respectively (11,145 ) (10,103 ) Accumulated other comprehensive loss (882 ) (1,038 ) Equity attributable to IQVIA Holdings Inc.'s stockholders 5,778 6,067 Noncontrolling interests 8 — Total stockholders' equity 5,786 6,067 Total liabilities and stockholders' equity $ 28,632 $ 26,899 Table 3IQVIA HOLDINGS INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(preliminary and unaudited) Six Months Ended June 30, (in millions) 2025 2024 Operating activities: Net income $ 515 $ 651 Adjustments to reconcile net income to cash provided by operating activities: Depreciation and amortization 541 533 Amortization of debt issuance costs and discount 11 11 Stock-based compensation 132 104 Losses from unconsolidated affiliates 14 1 Gain on investments, net (16 ) (12 ) Benefit from deferred income taxes (86 ) (80 ) Changes in operating assets and liabilities: Change in accounts receivable, unbilled services and unearned income 269 187 Change in other operating assets and liabilities (369 ) (285 ) Net cash provided by operating activities 1,011 1,110 Investing activities: Acquisition of property, equipment and software (293 ) (288 ) Acquisition of businesses, net of cash acquired (315 ) (221 ) Sales of marketable securities, net 2 — Investments in unconsolidated affiliates, net of payments received (27 ) (49 ) Investments in debt and equity securities (19 ) (2 ) Proceeds from sale of property, equipment and software — 25 Other 1 — Net cash used in investing activities (651 ) (535 ) Financing activities: Proceeds from issuance of debt 3,985 — Payment of debt issuance costs (35 ) — Repayment of debt and principal payments on finance leases (2,140 ) (86 ) Proceeds from revolving credit facility 875 375 Repayment of revolving credit facility (1,700 ) (585 ) Payments related to employee stock incentive plans (35 ) (60 ) Repurchase of common stock (1,032 ) — Contingent consideration and deferred purchase price payments (20 ) (10 ) Other (11 ) — Net cash used in financing activities (113 ) (366 ) Effect of foreign currency exchange rate changes on cash 90 (40 ) Increase in cash and cash equivalents 337 169 Cash and cash equivalents at beginning of period 1,702 1,376 Cash and cash equivalents at end of period $ 2,039 $ 1,545 Table 4IQVIA HOLDINGS INC. AND SUBSIDIARIESNET INCOME TO ADJUSTED EBITDA RECONCILIATION(preliminary and unaudited) Three Months Ended June 30, Six Months Ended June 30, (in millions) 2025 2024 2025 2024 Net Income $ 266 $ 363 $ 515 $ 651 Provision for income taxes 56 75 117 124 Depreciation and amortization 276 269 541 533 Interest expense, net 172 151 326 306 Loss (income) in unconsolidated affiliates 1 (2 ) 14 1 Stock-based compensation 60 48 132 104 Other expense (income), net (1) 29 (66 ) 44 (45 ) Loss on extinguishment of debt — — 4 — Restructuring and related expenses (2) 42 39 84 61 Acquisition related expenses 8 10 16 14 Adjusted EBITDA $ 910 $ 887 $ 1,793 $ 1,749 (1) Reflects certain non-operating income items, revaluations of contingent consideration and certain non-recurring expenses. (2) Reflects restructuring costs as well as accelerated expenses related to lease exits. Table 5IQVIA HOLDINGS INC. AND SUBSIDIARIESNET INCOME TO ADJUSTED NET INCOME RECONCILIATION(preliminary and unaudited) Three Months Ended June 30, Six Months Ended June 30, (in millions, except per share data) 2025 2024 2025 2024 Net Income $ 266 $ 363 $ 515 $ 651 Provision for income taxes 56 75 117 124 Purchase accounting amortization (1) 131 133 256 262 Loss (income) in unconsolidated affiliates 1 (2 ) 14 1 Stock-based compensation 60 48 132 104 Other expense (income), net (2) 29 (66 ) 44 (45 ) Loss on extinguishment of debt — — 4 — Restructuring and related expenses (3) 42 39 84 61 Acquisition related expenses 8 10 16 14 Adjusted Pre Tax Income $ 593 $ 600 $ 1,182 $ 1,172 Adjusted tax expense (107 ) (113 ) (217 ) (217 ) Adjusted Net Income $ 486 $ 487 $ 965 $ 955 Adjusted earnings per share attributable to common stockholders: Basic $ 2.83 $ 2.67 $ 5.56 $ 5.25 Diluted $ 2.81 $ 2.64 $ 5.50 $ 5.18 Weighted average common shares outstanding: Basic 171.8 182.2 173.7 182.0 Diluted 173.2 184.3 175.3 184.3 (1) Reflects all the amortization of acquired intangible assets. (2) Reflects certain non-operating income items, revaluations of contingent consideration and certain non-recurring expenses. (3) Reflects restructuring costs as well as accelerated expenses related to lease exits. Table 6IQVIA HOLDINGS INC. AND SUBSIDIARIESNET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW RECONCILIATION(preliminary and unaudited) Three Months Ended June 30, Six Months Ended June 30, (in millions) 2025 2024 2025 2024 Net Cash provided by Operating Activities $ 443 $ 588 $ 1,011 $ 1,110 Acquisition of property, equipment and software (151 ) (143 ) (293 ) (288 ) Free Cash Flow $ 292 $ 445 $ 718 $ 822 Table 7IQVIA HOLDINGS INC. AND SUBSIDIARIESCALCULATION OF GROSS AND NET LEVERAGE RATIOSAS OF JUNE 30, 2025(preliminary and unaudited) (in millions) Gross Debt, net of Unamortized Discount and Debt Issuance Costs, as of June 30, 2025 $ 15,490 Net Debt as of June 30, 2025 $ 13,451 Adjusted EBITDA for the twelve months ended June 30, 2025 $ 3,728 Gross Leverage Ratio (Gross Debt/LTM Adjusted EBITDA) 4.16 x Net Leverage Ratio (Net Debt/LTM Adjusted EBITDA) 3.61 x View source version on Contacts Kerri Joseph, IQVIA Investor Relations (
Zawya
11 hours ago
- Business
- Zawya
Binghatti Holding H1 2025 profit surges almost threefold to record AED 1.82bln
H1 2025 Key Highlights Net Profit Jumps 172% YoY to AED 1.82 billion Total Sales Increase 60% YoY to AED 8.8 billion Revenue Advances 189% YoY to AED 6.3 billion 61% of Sales to Non-Residents, Underscoring Dubai's Status as a Global Safe Haven Seven Projects Launched and Four Delivered, Demonstrating Speed and Execution Strength BinGhatti Capital Launched, Targeting USD 1 Billion in Private Credit and Real Estate Strategies Major Megaplot Acquired in Nad Al Sheba 1 for First Master-Planned Community Strong Pipeline for H2, with Market Fundamentals Remaining Robust Muhammad BinGhatti, Chairman ' The first half of 2025 has been a period of exceptional growth for Binghatti Holding and the extraordinary year-on-year growth of our net profit and revenue is a reflection of the market's confidence in our differentiated model, one that is built around architectural excellence, speed of execution, and integrated value creation across the entire real estate ecosystem. As Dubai continues to attract global capital and high-net-worth individuals, our developments have become increasingly relevant to an international audience. The rising share of non-resident buyers speaks volumes about both our reach and Dubai's position as a safe, fast-growing investment destination. Meanwhile, our expansion into regulated asset management through the launch of Binghatti Capital is an operational milestone that represents a leap forward in how we fund and structure our expanding development portfolio. With the acquisition of our Nad Al Sheba megaplot, we are laying the foundations for our next chapter, one that will be defined by creating master-planned curated communities that will shape the future of luxury living.' Katralnada Binghatti, CEO 'Our H1 2025 results and operational achievements underscore the discipline, agility, and long-term thinking that drive every aspect of our business. Launching seven projects and handing over four in just six months demonstrates our operational leadership in the market and our deep commitment to on time delivery. Our growing backlog, diversified landbank, and expanding portfolio of unique branded residences created in partnership with global icons Bugatti, Mercedes-Benz Jacob & Co. provide the market with luxury living, investment value and architectural distinction. BinGhatti Holding sets itself apart in the market by being active across the entire real estate ecosystem, from land acquisition and architectural design, through construction, sales, and aftercare, all the way to capital structuring and institutional fundraising. In this regard, the launch of Binghatti Capital, a DFSA-regulated firm headquartered in DIFC, adds a further dimension to our dynamic business model, giving us the regulatory and operational infrastructure to offer institutional-grade investment solutions. Binghatti Capital's private credit and real estate strategies will allow us to attract and deploy capital in a targeted manner while reinforcing the Group's integrated approach to real estate development. With continued robust demand for Dubai real estate amid the steady growth of the Emirate's population, and a strong funding platform in place, we are well-positioned to meet the rising demand for across the entire real estate product spectrum.' Dubai, UAE – Binghatti Holding Ltd, a leading UAE luxury real estate developer, reported record financial results for the first half of 2025, with year-on-year profit and revenue almost tripling, driven by the continued demand for Binghatti developments. Net profit in the first half of 2025 rose 172% year-on-year to AED 1.82 billion, compared to AED 668 million in the same period last year. Total sales reached AED 8.8 billion, representing a 60% year-on-year increase, while revenue surged almost threefold to AED 6.3 billion, making the Company one of the fastest growing in Dubai's real estate market. The Group also saw strong expansion of its development pipeline. As of 30 June 2025, Binghatti's revenue backlog reached AED 12.5 billion, compared to AED 6.6 billion in the same period last year. The surge in backlog was driven by the launch of seven new projects, while five projects were successfully delivered during the first half, handing over 1,441 units into the market. Branded Residence Drive Global Investor Demand Binghatti's flagship branded residences, developed in collaboration with world-renowned luxury partners Bugatti, Mercedes-Benz, and Jacob & Co. continue to resonate with global customers. The Company's ability to blend architectural innovation with iconic design has attracted an elite international clientele, including Brazilian football star Neymar Jr. and acclaimed opera singer Andrea Bocelli, reflecting Binghatti's status as the preferred ultra-luxury brand for investors around the round the world. In H1 2025, 61% of Binghatti's sales were made to non-resident buyers, up from 55% a year earlier, underscoring Dubai's safe-haven appeal and BinGhatti's pro-active marketing, which include the launch of a London sales office in July. Leading buyer nationalities in H1 2025 included India, Turkey and China. Supporting Strong Local Demand Through Strategic Financing Solutions, PropTech While international investors continue to play a growing role in driving sales, Binghatti also continued to benefit from strong local demand, supported by the UAE's expanding population, and ongoing investment in infrastructure and housing accessibility. The Company continued to broaden its domestic customer base by improving affordability and access to high-quality real estate developments. In May 2025, Binghatti signed a landmark Memorandum of Understanding with Abu Dhabi Islamic Bank (ADIB) to offer Sharia-compliant home financing solutions tailored to both ready and off-plan residential units. Under the agreement, eligible buyers will be able to secure financing once construction reaches 35% completion and 50% of payments have been made, a flexible structure designed to unlock new demand among UAE-based homeowners and investors. To further support access to homeownership, Binghatti Holding was selected in July by the Dubai Land Department (DLD) and the Dubai Department of Economy and Tourism (DET) as one of 13 developers participating in the newly launched First-Time Home Buyer (FTHB) Programme. As part of this initiative, Binghatti has committed to allocating at least 10% of its newly launched and existing residential units priced under AED 5 million exclusively to eligible first-time buyers. The earmarked units will be made available ahead of public launches, ensuring early access and greater affordability for UAE residents entering the property market for the first time. In addition to prioritised access, Binghatti is offering exclusive financial incentives to FTHB participants, including discounts on selected properties and reduced administrative fees, with enhanced packages for both Emiratis and expatriates. The initiative supports Dubai's broader economic and social development goals, including the D33 Economic Agenda which targets AED 1 trillion in real estate transactions In July, Binghatti also became a founding partner of the Dubai PropTech Hub, a joint initiative of the DIFC Innovation Hub and the Dubai Land Department. The Hub, which aims to attract $300 million in venture capital by 2030, will position Binghatti at the forefront of real estate innovation through access to emerging technologies such as AI, blockchain, and sustainable smart infrastructure. As a founding partner, Binghatti will benefit from early engagement with next-generation PropTech start-ups through the Hub's Living Lab, Scale-up Accelerator, and bespoke innovation programs. Accelerated Development and Landmark Land Acquisition Binghatti currently has around 20,000 units under development across about 30 projects in prime residential areas across Dubai, including Downtown, Business Bay, Jumeirah Village Circle, Al Jaddaf, Meydan, Dubai Science Park, Dubai Production City, and Sports City. During the first half, Binghatti launched seven new projects featuring 5,000 units spread over 3.8 million square feet and and handed over five developments comprising 1,441 units over 1 million square feet. The company acquired a landmark megaplot in Nad Al Sheba 1, in the heart of Dubai's sought-after Meydan district with over 9 million square feet of gross floor area, which will serve as the foundation for its first master-planned residential community in Dubai with a total development value of over AED 25 billion. Strengthened Credit Profile Recognised by Global Rating Agencies In the first half of 2025, Binghatti's credit profile was formally recognised by leading global rating agencies. In March, Moody's Ratings assigned Binghatti a first-time Ba3 Corporate Family Rating (CFR) with a stable outlook, citing the Company's strong market position in Dubai's luxury real estate sector, its vertically integrated operating model, and prudent financial management. The agency highlighted Binghatti's low leverage, strong liquidity, and effective cost control as key credit strengths, alongside its strategic expansion through branded developments and a deep pipeline of projects. Shortly after, Fitch Ratings upgraded Binghatti's Long-Term Issuer Default Rating (IDR) and senior unsecured debt to BB- from B+, also with a stable outlook. The upgrade reflected Binghatti's resilient growth trajectory, robust liquidity - including a low net debt-to-EBITDA ratio of just 0.8x - and its ability to self-fund future projects through internally generated cash flows. Both agencies recognised the Company's strengthened corporate governance framework and the institutional credibility brought by its inaugural USD 500 million sukuk, which is listed on both the London Stock Exchange and Nasdaq Dubai. Positive Outlook Amid Structural Supply Constraints Dubai's real estate market continues to show structural strength, supported by a growing population, stable governance, and surging global investor interest. As of June 2025, Dubai's population surpassed 3.75 million and is expected to exceed 4 million by the end of 2026. In the first half of 2025 alone, over 19,700 new residential units were handed over, primarily in JVC, Al Merkadh and Business Bay. However, delivery across core and premium submarkets has not kept pace with demand. This gap is even more evident in the luxury and branded segment, where sustained demand continues to drive strong absorption rates. Rental values in prime zones such as Marina, Business Bay, and Downtown Dubai are up significantly year-on-year, clear indicators of supply pressure and investor appetite. About Binghatti Holding Ltd.: Binghatti Holding Ltd. is a renowned Emirati brand in the real estate development sector, holding a leading position with a portfolio exceeding 80 projects valued at over AED 70 billion. Binghatti Holding is led by Chairman Muhammad BinGhatti, whose innovative vision aims to deliver luxurious projects that reflect refined artistic taste and high standards in design and quality. Binghatti Holding has successfully delivered over 12,000 residential units since inception, achieving remarkable milestones in collaboration with global brands such as Bugatti, Mercedes-Benz, and Jacob & Co. Binghatti Holding continues to expand its real estate portfolio to meet the growing market demands, focusing on delivering residential projects that elevate the level of luxury in Dubai. Further Information for Investors: For further information on Binghatti Holding its investment capabilities, please visit our website ( Elena Ponceca Head of Investor Relations Binghatti Holding ir@ Further Information for Media: Mahmoud Kassem Brunswick mkassem@
Yahoo
13 hours ago
- Business
- Yahoo
Speedy Hire Full Year 2025 Earnings: Misses Expectations
Speedy Hire (LON:SDY) Full Year 2025 Results Key Financial Results Revenue: UK£416.6m (down 1.2% from FY 2024). Net loss: UK£1.10m (down by 141% from UK£2.70m profit in FY 2024). UK£0.002 loss per share (down from UK£0.006 profit in FY 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Speedy Hire Revenues and Earnings Miss Expectations Revenue missed analyst estimates by 2.6%. Earnings per share (EPS) was also behind analyst expectations. Looking ahead, revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Trade Distributors industry in the United Kingdom. Performance of the British Trade Distributors industry. The company's shares are up 2.4% from a week ago. Risk Analysis It's necessary to consider the ever-present spectre of investment risk. We've identified 3 warning signs with Speedy Hire (at least 1 which is potentially serious), and understanding them should be part of your investment process. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
14 hours ago
- Business
- Yahoo
Bastei Lübbe Full Year 2025 Earnings: Revenues Disappoint
Bastei Lübbe (ETR:BST) Full Year 2025 Results Key Financial Results Revenue: €114.0m (up 3.3% from FY 2024). Net income: €11.3m (up 30% from FY 2024). Profit margin: 9.9% (up from 7.9% in FY 2024). The increase in margin was driven by higher revenue. EPS: €0.86 (up from €0.66 in FY 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Bastei Lübbe Earnings Insights Looking ahead, revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Media industry in Germany. Performance of the German Media industry. The company's shares are up 2.5% from a week ago. Risk Analysis You should always think about risks. Case in point, we've spotted 2 warning signs for Bastei Lübbe you should be aware of, and 1 of them makes us a bit uncomfortable. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
